NCT04279392View on ClinicalTrials.gov

Healthy Body, Healthy Bones After Bariatric Surgery Trial

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

December 30, 2022

Study Completion Date

December 30, 2022

Conditions
Bariatric Surgery CandidateBone LossBone Resorption
Interventions
DRUG

Zoledronic Acid 5 mg/Bag 100 ml Inj

Zoledronic acid infusion

DRUG

Placebos

Saline infusion

Trial Locations (1)

68198

Bariatric Center, Nebraska Medicine, Omaha

All Listed Sponsors
lead

University of Nebraska

OTHER

NCT04279392 - Healthy Body, Healthy Bones After Bariatric Surgery Trial | Biotech Hunter | Biotech Hunter